FDA Warns of PML Case With Gilenya

(MedPage Today) -- SILVER SPRING, Md. -- A patient being treated for multiple sclerosis and who had no history of using natalizumab (Tysabri) developed progressive multifocal leukoencephalopathy (PML) while taking fingolimod (Gilenya), the FDA said.
Source: MedPage Today Public Health - Category: American Health Source Type: news